Submitted:
15 July 2025
Posted:
18 July 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
- (1)
- new treatment for prolapse (pessary placement or surgery)
- (2)
- anatomical outcomes, defined as recurrence of apical prolapse (stages II-and any non-static POP-Q measurement greater than 0
- (3)
-
symptoms, measured using the validated PFDI-20 questionnaires(specifically, the question: "Do you notice a sensation of lump in your genitals?", including the analysis of the questionnaires (POPDI-6, CRAD-8 and UDI-6) and PISQ-12.
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| POP | Pelvic organ prolapse |
| SCL | Sacropexy (Laparoscopic) |
| LLS | Laparoscopic Lateral Suspension |
| POPQ | Pelvic organ prolapse quantification |
| PFDI-20 | Pelvic Floor Distress Inventory Questionnaire-Short Form 20 |
| POPDI-6 | Pelvic Organ Prolapse Distress Inventory |
| CRAD-8 | Colorectal–Anal Distress Inventory |
| UDI-6 | Urinary Distress Inventory |
| PISQ-12 | Pelvic Organ prolapse/Urinary Incontinence Sexual Function Questionnaire |
| BMI | Body mass index |
Acknowledgments
References
- Maher, C.; Feiner, B.; Baessler, K.; Christmann-Schmid, C.; Haya, N.; Brown, J. Surgery for Women with Anterior Compartment Prolapse. Cochrane Database of Systematic Reviews 2016, 2016. [Google Scholar] [CrossRef] [PubMed]
- Larouche, M.; Belzile, E.; Geoffrion, R. Surgical Management of Symptomatic Apical Pelvic Organ Prolapse: A Systematic Review and Meta-Analysis. In Proceedings of the Obstetrics and Gynecology; Lippincott Williams and Wilkins, June 1 2021; Vol. 137, pp. 1061–1073. [CrossRef]
- Noé, K.G.; Schiermeier, S.; Alkatout, I.; Anapolski, M. Laparoscopic Pectopexy: A Prospective, Randomized, Comparative Clinical Trial of Standard Laparoscopic Sacral Colpocervicopexy with the New Laparoscopic Pectopexy-Postoperative Results and Intermediate-Term Follow-up in a Pilot Study. J Endourol 2015, 29, 210–215. [Google Scholar] [CrossRef] [PubMed]
- Yang, Y.; Li, Z.; Si, K.; Dai, Q.; Qiao, Y.; Li, D.; Zhang, L.; Wu, F.; He, J.; Wu, G. Effectiveness of Laparoscopic Pectopexy for Pelvic Organ Prolapse Compared with Laparoscopic Sacrocolpopexy. J Minim Invasive Gynecol 2023, 30, 833–840.e2. [Google Scholar] [CrossRef] [PubMed]
- Lin, Y.; Liu, J.J.; Fang, K.; Wu, H.; Li, N. Pectopexy Compared with Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse: A Systematic Review and Meta-Analysis of Clinical Outcomes. European Journal of Obstetrics and Gynecology and Reproductive Biology 2025, 312. [Google Scholar] [CrossRef] [PubMed]
- Dubuisson, J.B.; Yaron, M.; Wenger, J.M.; Jacob, S. Treatment of Genital Prolapse by Laparoscopic Lateral Suspension Using Mesh: A Series of 73 Patients. J Minim Invasive Gynecol 2008, 15, 49–55. [Google Scholar] [CrossRef] [PubMed]
- Isenlik, B.S.; Aksoy, O.; Erol, O.; Mulayim, B. Comparison of Laparoscopic Lateral Suspension and Laparoscopic Sacrocolpopexy with Concurrent Total Laparoscopic Hysterectomy for the Treatment of Pelvic Organ Prolapse: A Randomized Controlled Clinical Trial. Int Urogynecol J 2023, 34, 231–238. [Google Scholar] [CrossRef] [PubMed]
- Coolen, A.L.W.M.; Bui, B.N.; Dietz, V.; Wang, R.; van Montfoort, A.P.A.; Mol, B.W.J.; Roovers, J.P.W.R.; Bongers, M.Y. The Treatment of Post-Hysterectomy Vaginal Vault Prolapse: A Systematic Review and Meta-Analysis. Int Urogynecol J 2017, 28, 1767–1783. [Google Scholar] [CrossRef] [PubMed]
- Chuang, F.C.; Chou, Y.M. ; Ling, &; Wu, Y.; Tsai, &; Yang, H.; Chen, W.H.; Kuan, &; Huang, H. Laparoscopic Pectopexy: The Learning Curve and Comparison with Laparoscopic Sacrocolpopexy. [CrossRef]
- Shah, N.M.; Berger, A.A.; Zhuang, Z.; Tan-Kim, J.; Menefee, S.A. Long-Term Reoperation Risk after Apical Prolapse Repair in Female Pelvic Reconstructive Surgery. Am J Obstet Gynecol 2022, 227, 306.e1–306.e16. [Google Scholar] [CrossRef] [PubMed]
- Akladios, C.Y.; Dautun, D.; Saussine, C.; Baldauf, J.J.; Mathelin, C.; Wattiez, A. Laparoscopic Sacrocolpopexy for Female Genital Organ Prolapse: Establishment of a Learning Curve. European Journal of Obstetrics and Gynecology and Reproductive Biology 2010, 149, 218–221. [Google Scholar] [CrossRef] [PubMed]
- Plotti, F.; Martinelli, A.; Terranova, C.; De Cicco Nardone, C.; Montera, R.; Luvero, D.; Guzzo, F.; Di Donato, V.; Cundari, G.B.; Manco, S.; et al. Laparoscopic Lateral Suspension (LLS) for Pelvic Organ Prolapse (POP): Update and Systematic Review of Prospective and Randomised Trials. J Clin Med 2025, 14. [Google Scholar] [CrossRef] [PubMed]
- Malanowska-Jarema, E.; Starczewski, A.; Melnyk, M.; Oliveira, D.; Balzarro, M.; Rubillota, E. A Randomized Clinical Trial Comparing Dubuisson Laparoscopic Lateral Suspension with Laparoscopic Sacropexy for Pelvic Organ Prolapse: Short-Term Results. J Clin Med 2024, 13. [Google Scholar] [CrossRef] [PubMed]
- Ñíguez-Sevilla, I.; Sánchez-Ferrer, M.L.; Ruiz-Cotorruelo, V.L.; Wilczak, M.; Chmaj-Wierzchowska, K.; Solano-Calvo, J.A.; Pérez-Muñuzuri, M.E.; Salinas-Peña, J.R.; Arense-Gonzalo, J.J. Preliminary Results of a Multicenter Randomized Clinical Trial for Laparoscopic Repair of Pelvic Organ Prolapse: Sacropexy vs. Laparoscopic Lateral Suspension. J Clin Med 2025, 14. [Google Scholar] [CrossRef] [PubMed]
- Lee, R.K.; Mottrie, A.; Payne, C.K.; Waltregny, D. A Review of the Current Status of Laparoscopic and Robot-Assisted Sacrocolpopexy for Pelvic Organ Prolapse. Eur Urol 2014, 65, 1128–1137. [Google Scholar] [CrossRef] [PubMed]
- Wang, Q.; Manodoro, S.; Jiang, X.; Lin, C. Efficacy and Safety of Laparoscopic Lateral Suspension with Mesh for Pelvic Organ Prolapse: A Systematic Review and Meta-Analysis. Acta Obstet Gynecol Scand 2025. [CrossRef] [PubMed]
| CHARACTERISTICS | SACROPEXY (N=115) | DUBUISSON (LLS) (N=33) | PECTOPEXY (N=32) | P-VALUE |
| Age (years), mean (SD) | 54.77 (10.13) | 57 (7.64) | 57.41 (9.90) | 0.148 |
| BMI (kg/m²), mean (SD) | 25.67 (3.69) | 26.78 (3.42) | 27.51 (4.45) | 0.025 |
| Multiparous, n (%) | 100 | 94.3 | 100 | 0.014 |
| Vaginal births, n (%) | 99.13 | 94.29 | 100 | 0.356 |
| Previous hysterectomy, n (%) | 21.7 | 5.7 | 28.1 | 0.049 |
| Apical or uterine prolapse stage ≥II | ||||
| Stage II (%) | 26.5 | 59.4 | 58.1 | |
| Stage III (%) | 56.6 | 38.2 | 29.0 | |
| Stage IV (%) | 16.8 | 6.3 | 12.9 | 0.001 |
| Anterior prolapse or cystocele ≥II | ||||
| Stage II (%) | 26.9 | 11.8 | 10.0 | |
| Stage III (%) | 53.8 | 70.6 | 63.3 | |
| Stage IV (%) | 19.4 | 17.6 | 26.7 | 0.110 |
| Posterior prolapse or rectocele ≥II | ||||
| Stage II (%) | 55.9 | 5.0 | 87.5 | |
| Stage III (%) | 32.4 | - | 12.5 | |
| Stage IV (%) | 11.8 | - | - | 0.205 |
| Aa | 1.89 (1.44) | 1.77 (1.00) | 1.71 (1.05) | 0.315 |
| Ba | 2.40 (2.20) | 2.40 (1.17) | 2.40 (1.43) | 0.942 |
| C or D | 2.55 (2.76) | 0.650 (2.22) | 1.13 (2.58) | 0.003 |
| Ap | -0.915 (1.66) | -2.21 (0.77) | -1.38 (2.49) | 0.001 |
| Bp | -0.74 (2.07) | -2.13 (1.33) | -1.72 (1.93) | 0.002 |
| gh | 5.86 (1.64) | 5.25 (1.60) | 5.36 (1.18) | 0.177 |
| pb | 2.82 (0.76) | 2.98 (1.76) | 3.23 (0.82) | 0.021 |
| TVL | 7.61 (1.24) | 7.25 (0.042) | 6.92 (1.20) | 0.058 |
| Hiatal area | 32.93 (8.76) | 32.45 (7.97) | 31.31 (7.07) | 0.464 |
| POPDI-6 | 13.79 (5.66) | 13.50 (5.71) | 12.44 (4.56) | 0.691 |
| CRAD-8 | 8.63 (5.87) | 4.94 (4.73) | 8.93 (6.06) | 0.077 |
| UDI-6 | 13.44 (6.11) | 12.06 (6.72) | 9.25 (5.82) | 0.118 |
| Constipation (%) | 9.6 | 14.3 | 28.1 | 0.026 |
| PISQ-12 | 27.00 (10.23) | 30.80 (9.30) | 29.09 (7.56) | 0.522 |
| Surgical Results | SACROPEXY | DUBUISSON (LLS) | PECTOPEXY | P-VALUE |
| Subtotal hysterectomy, n (%) | 78.3 | 5.7 | 28.1 | 0.000 |
| Operative time (min) | 214.44 (65.38) | 108.79 (34.93) | 163.83 (49.80) | 0.000 |
| Intraoperative complications | 7 | 2.7 | 0 | 0.214 |
| Pessary (%) | 0.9 | - | - | 0.746 |
| Surgical reintervention (%) | 5.2 | 5.7 | - | 0.406 |
| Any POP-Q ≥ 0 (%) | 7.4 | 3.3 | 20 | 0.084 |
| Apical prolapse recurrence ≥II | ||||
| Stage II (%) | - | - | 0.9 | |
| Stage III (%) | - | 2.9 | - | |
| Stage IV (%) | - | - | - | 0.309 |
| Anterior prolapse recurrence ≥II | ||||
| Stage II (%) | 0.9 | - | - | |
| Stage III (%) | 1.7 | - | - | |
| Stage IV (%) | - | - | - | 0.363 |
| Posterior prolapse recurrence ≥II | ||||
| Stage II (%) | 1.7 | 17.1 | 6.3 | |
| Stage III (%) | 0.9 | - | 3.1 | |
| Stage IV (%) | - | - | - | 0.019 |
| Aa (postsurgery) | -2.37 (1.01) | -2.20 (1.17) | -2.14 (1.18) | 0.690 |
| Ba (postsurgery) | -2.19 (1.18) | -2.43 (1.06) | -2.14 (1.32) | 0.578 |
| CoD(postsurgery) | -5.99 (2.25) | -5.58 (1.42) | -4.76 (3.13) | 0.132 |
| Ap (postsurgery) | -2.38 (1.07) | -2.48 (1.03) | -1.96 (1.29) | 0.117 |
| Bp (postsurgery) | -2.46 (1.04) | -2.48 (1.03) | -2.04 (1.39) | 0.201 |
| gh (postsurgery) | 4.14 (1.10) | 3.75 (1.12) | 4.22 (1.29) | 0.335 |
| pb (postsurgery) | 3.20 (0.72) | 3.57 (0.98) | 3.28 (0.81) | 0.344 |
| TVL(postsurgery) | 8.81 (1.37) | 7.93 (1.15) | 7.74 (1.18) | 0.000 |
| POPDI-6 | 5.89 (4.87) | 4.03 (3.62) | 3.65 (4.13) | 0.089 |
| CRAD-8 | 7.60 (6.86) | 4.17 (4.09) | 5.05 (4.78) | 0.081 |
| UDI-6 | 7.40 (6.62) | 5.59 (6.01) | 5.40 (5.35) | 0.357 |
| Genital bulge sensation (%) | 3.5 | 2.9 | 0 | 0.567 |
| PISQ-12 | 31.13 (11.89) | 31.48 (11.39) | 31.90 (12.25) | 0.987 |
| Maximum follow-up time (months) | 17.09 (13.92) | 7.60 (5.75) | 7.59 (8.73) | 0.000 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).